Back to Agenda
Session 8, Track B: Next-Gen Pharmacovigilance: AI, NLP and Beyond
Session Chair(s)
Betty Duarte, PharmD, MBA
Pharmacovigilance Director CAN & LATAM
Pfizer, Costa Rica
Lina Valero, MD, MBA, MSc
Regional PV Head LATAM
Opella Healthcare, Colombia
Learn how the AI and NLP are revolutionizing pharmacovigilance, enhancing drug safety monitoring, streamline case processing and enable predictive analytics or more accurate adverse event detection and signal management. Gain insights into the future of PV as we push beyond the traditional methods not next generation safety surveillance.
Learning Objective : - Describe how AI and NLP enhance adverse event detection, signal management, and risk assessment in pharmacovigilance
- Assess the potential of advanced technologies (machine learning, real world data analytics and automations) in transforming traditional pharmacovigilance processes
- Identify practical use cases where Ai and NLP can streamline case processing, improve data accuracy, enable predictive safety analytics in PV operations
Speaker(s)
Innovation In Pharmacovigilance: Strategies for Personalized Safety
Felix Arellano, MD, PhD, FISPE
Hoffmann-La Roche Limited, Switzerland
Global Head Safety Risk Management
Smart Pharmacovigilance: AI in Drug Safety
Lina Valero, MD, MBA, MSc
Opella Healthcare, Colombia
Regional PV Head LATAM
Artificial Intelligence for Pharmacovigilance
Flávia Moreira Cruz, PharmD
ANVISA, Brazil
Specialist at Pharmacovigilance Officer (GFARM)
Have an account?